What to watch with Insulin and longevity?

The relationship between insulin and longevity is nuanced. In model organisms, reduced insulin/IGF-1 signaling consistently extends lifespan. In humans, the picture is more complex: good insulin sensitivity supports metabolic health and reduces age-related disease risk, while chronic hyperinsulinemia and insulin resistance are linked to accelerated aging. Some longevity-associated variants (e.g., in FOXO3, IGF1R) modulate insulin signaling, but consumer DNA tests rarely provide actionable insights on this axis. The effect of any single SNP is small, and lifestyle factors (diet, exercise, sleep) dominate. Commercial claims that a specific insulin-related gene variant predicts your lifespan are overblown. The most evidence-based advice remains: maintain insulin sensitivity through a balanced diet, regular physical activity, and weight management. This is where the strongest human evidence lies. Genetic testing for insulin and longevity is currently not clinically validated for individual prediction. Evidence: human-moderate for the insulin–longevity link in general, but for consumer genetics it is often unclear or marketing-driven.